{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:50:15Z","timestamp":1762419015210,"version":"build-2065373602"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.remnie.2023.03.002","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T14:03:17Z","timestamp":1679493797000},"page":"289-295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The relationship between immunohistochemical parameters, bone marrow fibrosis and bone marrow 18F-FDG uptake in multiple myeloma patients undergoing PET\/CT examination"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7487-9044","authenticated-orcid":false,"given":"Ali Ozan","family":"Oner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8500-0744","authenticated-orcid":false,"given":"\u00c7i\u011fdem","family":"\u00d6zdemir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4017-4668","authenticated-orcid":false,"given":"Filiz","family":"Yava\u015fo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-4595","authenticated-orcid":false,"given":"Yi\u011fit","family":"\u015eenol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7449-9954","authenticated-orcid":false,"given":"Sena Naz","family":"Ads\u0131z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.remnie.2023.03.002_bib0005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJMra1011442","article-title":"Multiple Myeloma","volume":"364","author":"Palumbo","year":"2011","journal-title":"N Engl J Med [Internet]"},{"key":"10.1016\/j.remnie.2023.03.002_bib0010","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.13562","article-title":"Evaluation of measurable residual disease in multiple myeloma by multiparametric flow cytometry: Current paradigm, guidelines, and future applications","volume":"43","author":"Soh","year":"2021","journal-title":"Int J Lab Hematol"},{"issue":"1","key":"10.1016\/j.remnie.2023.03.002_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4065\/78.1.21","article-title":"Review of 1027 patients with newly diagnosed multiple myeloma","volume":"78","author":"Kyle","year":"2003","journal-title":"Mayo Clin Proc [Internet]"},{"issue":"9","key":"10.1016\/j.remnie.2023.03.002_bib0020","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","author":"Drayson","year":"2001","journal-title":"Blood [Internet]"},{"issue":"9","key":"10.1016\/j.remnie.2023.03.002_bib0025","first-page":"924","article-title":"Non-secretory myeloma: a clinician\u2019s guide","volume":"27","author":"Lonial","year":"2013","journal-title":"Oncology (Williston Park) [Internet]"},{"issue":"3","key":"10.1016\/j.remnie.2023.03.002_bib0030","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3324\/haematol.11080","article-title":"Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders","volume":"93","author":"Rawstron","year":"2008","journal-title":"Haematologica [Internet]"},{"issue":"4","key":"10.1016\/j.remnie.2023.03.002_bib0035","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","article-title":"Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma","volume":"121","author":"Lin","year":"2004","journal-title":"Am J Clin Pathol [Internet]"},{"key":"10.1016\/j.remnie.2023.03.002_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/893243","article-title":"Expression of myeloid antigen in neoplastic plasma cells is related to adverse prognosis in patients with multiple myeloma","volume":"2014","author":"Shim","year":"2014","journal-title":"Biomed Res Int [Internet]"},{"key":"10.1016\/j.remnie.2023.03.002_bib0045","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1200\/JCO.2007.15.4120","article-title":"Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA\/GEM cooperative study groups on patients uniformly treated with high-dose therapy","volume":"26","author":"Mateo","year":"2008","journal-title":"J Clin Oncol [Internet]"},{"issue":"5","key":"10.1016\/j.remnie.2023.03.002_bib0050","first-page":"512","article-title":"Significance of bone marrow fibrosis in multiple myeloma","volume":"39","author":"Subramanian","year":"2007","journal-title":"Pathology [Internet]"},{"issue":"1","key":"10.1016\/j.remnie.2023.03.002_bib0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/0019-509X.48594","article-title":"Prognostic significance of bone marrow histology in multiple myeloma","volume":"46","author":"Subramanian","year":"2009","journal-title":"Indian J Cancer [Internet]"},{"issue":"2","key":"10.1016\/j.remnie.2023.03.002_bib0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.cancergencyto.2006.05.017","article-title":"Effects of cyclin D1 (CCND1) polymorphism on susceptibility to lung cancer in a North Indian population","volume":"170","author":"Sobti","year":"2006","journal-title":"Cancer Genet Cytogenet [Internet]"},{"issue":"7015","key":"10.1016\/j.remnie.2023.03.002_bib0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature03094","article-title":"G1 cell-cycle control and cancer","volume":"432","author":"Massagu\u00e9","year":"2004","journal-title":"Nature [Internet]"},{"issue":"4","key":"10.1016\/j.remnie.2023.03.002_bib0070","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1182\/blood-2003-11-3837","article-title":"Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels","volume":"104","author":"Specht","year":"2004","journal-title":"Blood [Internet]"},{"key":"10.1016\/j.remnie.2023.03.002_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","article-title":"A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma","volume":"92","author":"Zamagni","year":"2007","journal-title":"Haematologica [Internet]"},{"issue":"6","key":"10.1016\/j.remnie.2023.03.002_bib0080","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(19)30309-2","article-title":"International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders","volume":"20","author":"Hillengass","year":"2019","journal-title":"Lancet Oncol [Internet]"},{"issue":"2","key":"10.1016\/j.remnie.2023.03.002_bib0085","first-page":"138","article-title":"A counting strategy for estimating plasma cell number in CD138-stained bone marrow core biopsy sections","volume":"38","author":"Smith","year":"2008","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.remnie.2023.03.002_bib0090","article-title":"CD56 expression in multiple myeloma: correlation with poor prognostic markers but no effect on outcome","volume":"225","author":"Koumpis","year":"2021","journal-title":"Pathol - Res Pract [Internet]"},{"issue":"8","key":"10.1016\/j.remnie.2023.03.002_bib0095","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1080\/10428194.2018.1563697","article-title":"LMP1 expression in bone marrow trephines of patients with multiple myeloma confers a survival advantage","volume":"60","author":"Rajput","year":"2019","journal-title":"Leuk Lymphoma [Internet]"},{"issue":"3","key":"10.1016\/j.remnie.2023.03.002_bib0100","doi-asserted-by":"crossref","first-page":"224","DOI":"10.31768\/2312-8852.2017.39(3):224-228","article-title":"Are CD44+\/CD24- cells the assumed cancer stem cells in breast cancer?","volume":"39","author":"Ryspayeva","year":"2017","journal-title":"Exp Oncol [Internet]"},{"issue":"8","key":"10.1016\/j.remnie.2023.03.002_bib0105","first-page":"1128","article-title":"European consensus on grading bone marrow fibrosis and assessment of cellularity","volume":"90","author":"Thiele","year":"2005","journal-title":"Haematologica [Internet]"},{"key":"10.1016\/j.remnie.2023.03.002_bib0110","doi-asserted-by":"crossref","DOI":"10.4274\/tjh.2017.0372","article-title":"Correlation between baseline 18F-FDG PET\/CT findings and CD38, CD138 expressing myeloma cells in bone marrow and clinical parameters in patiens with multiple myeloma","author":"Cengiz","year":"2018","journal-title":"Turkish J Hematol [Internet]"},{"key":"10.1016\/j.remnie.2023.03.002_bib0115","doi-asserted-by":"crossref","DOI":"10.4274\/tjh.2016.0394","article-title":"The assessment of CD56 and CD117 expressions at the time of the diagnosis in multiple myeloma patientsple myeloma patients","author":"Ceran","year":"2017","journal-title":"Turkish J Hematol [Internet]"},{"issue":"3","key":"10.1016\/j.remnie.2023.03.002_bib0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2141.2007.06807.x","article-title":"Bone marrow fibrosis: pathophysiology and clinical significance of increased bone marrow stromal fibres","volume":"139","author":"Kuter","year":"2007","journal-title":"Br J Haematol [Internet]"},{"issue":"3","key":"10.1016\/j.remnie.2023.03.002_bib0125","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/ajcp\/87.3.342","article-title":"Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases","volume":"87","author":"Bartl","year":"1987","journal-title":"Am J Clin Pathol [Internet]"},{"issue":"3","key":"10.1016\/j.remnie.2023.03.002_bib0130","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0002-9343(85)90307-9","article-title":"Plasma cell dyscrasia with marrow fibrosis. Clinicopathologic syndrome","volume":"79","author":"Vandermolen","year":"1985","journal-title":"Am J Med [Internet]"},{"issue":"3","key":"10.1016\/j.remnie.2023.03.002_bib0135","first-page":"359","article-title":"Histomorphology of multiple myeloma on bone marrow biopsy","volume":"47","author":"Singhal","year":"2004","journal-title":"Indian J Pathol Microbiol [Internet]"},{"key":"10.1016\/j.remnie.2023.03.002_bib0140","doi-asserted-by":"crossref","DOI":"10.1007\/s12185-022-03373-1","article-title":"Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease","author":"Koshiishi","year":"2022","journal-title":"Int J Hematol [Internet]"},{"issue":"1","key":"10.1016\/j.remnie.2023.03.002_bib0145","first-page":"141","article-title":"[Clinical characteristics and prognosis of multiple myeloma patients with myelofibrosis]","volume":"30","author":"Cheng","year":"2022","journal-title":"Zhongguo shi yan xue ye xue za zhi [Internet]"},{"issue":"5","key":"10.1016\/j.remnie.2023.03.002_bib0150","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","article-title":"Cyclin D1 is a nuclear protein required for cell cycle progression in G1","volume":"7","author":"Baldin","year":"1993","journal-title":"Genes Dev [Internet]"},{"issue":"10","key":"10.1016\/j.remnie.2023.03.002_bib0155","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/nrc2230","article-title":"Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics","volume":"7","author":"Jares","year":"2007","journal-title":"Nat Rev Cancer [Internet]"},{"issue":"6","key":"10.1016\/j.remnie.2023.03.002_bib0160","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.0959-9673.2005.00447.x","article-title":"Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma","volume":"86","author":"Thomas","year":"2005","journal-title":"Int J Exp Pathol [Internet]"},{"issue":"40","key":"10.1016\/j.remnie.2023.03.002_bib0165","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene [Internet]"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808923000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T08:45:24Z","timestamp":1762418724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808923000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2253808923000289"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2023.03.002","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The relationship between immunohistochemical parameters, bone marrow fibrosis and bone marrow 18F-FDG uptake in multiple myeloma patients undergoing PET\/CT examination","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2023.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2023.01.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}